Top Markets
#1 TENDIES TENDIES +36.52%
#2 Cash Cat Cash Cat +27.12%
#3 Asteroid Shiba Asteroid Shiba +16.52%
#4 MarsCoin MarsCoin +15.71%
#5 OSK OSK +15.36%
#6 龙虾 (Lobster) 龙虾 (Lobster) +10.48%
#7 Tornado Cash Tornado Cash +9.52%
#8 Threshold Network Threshold Network +9.46%
#9 Kite Kite +7.57%
#10 Ardor Ardor +6.84%
Coin of the day
TENDIES TENDIES
設定
言語
日本
通貨
USD
テーマ
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
株式のランク #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
株価
$3.78
最終同期: 2026-03-17
時価総額
$276.54M
変化（1日）
0.00%
変化（1年）
45.53%
国
CA
取引 NervGen Pharma Corp. (NGEN)

カテゴリー

Healthcare
NervGen Pharma Corp.（NGEN）の配当履歴
NervGen Pharma Corp.（証券コード：NGEN）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのNervGen Pharma Corp.（NGEN）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH